Literature DB >> 10683482

The protective effects of PBN against MPTP toxicity are independent of hydroxyl radical trapping.

B Ferger1, P Teismann, C D Earl, K Kuschinsky, W H Oertel.   

Abstract

To study the mechanism of the protective effect of the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PBN) against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) toxicity hydroxyl radicals and functional parameters of neuroprotection were determined. C57BL/6 mice received PBN (100 mg/kg IP) over a time period of 15 days and on day 8 MPTP (40 mg/kg SC). On day 15 striatal levels of dopamine, serotonin, and metabolites were analyzed. For radical determination mice received a single injection of salicylic acid (SA) (100 mg/kg IP) in the time period of 0.5 h before to 72 h after MPTP injection. In vivo maximum hydroxyl radical levels indicated by 2,3-dihydroxybenzoic acid/SA ratios were obtained 4 h after MPTP injection, and were not affected by PBN treatment. However, the MPTP-induced mortality, reduction of locomotor activity, continuous loss of body weight, and striatal dopamine depletion were significantly less pronounced in PBN-treated animals. These results elucidate the time course of hydroxyl free radical formation in MPTP toxicity. PBN improved the functional parameters of neuroprotection against MPTP toxicity, but there is no evidence for hydroxyl radical scavenging properties to this effect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10683482     DOI: 10.1016/s0091-3057(99)00229-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  5 in total

1.  A Simple Microfluidic Electrochemical HPLC Detector for Quantifying Fenton Reactivity from Welding Fumes.

Authors:  Thanakorn Pluangklang; John B Wydallis; David M Cate; Duangjai Nacapricha; Charles S Henry
Journal:  Anal Methods       Date:  2014-10-21       Impact factor: 2.896

Review 2.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

Review 3.  Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Authors:  Susan Duty; Peter Jenner
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease.

Authors:  Rattanavijit Vijitruth; Mei Liu; Dong-Young Choi; Xuan V Nguyen; Randy L Hunter; Guoying Bing
Journal:  J Neuroinflammation       Date:  2006-03-27       Impact factor: 8.322

5.  Pretreatment with Human Lactoferrin Had a Positive Effect on the Dynamics of Mouse Nigrostriatal System Recovery after Acute MPTP Exposure.

Authors:  Marina Yu Kopaeva; Anton B Cherepov; Mikhail V Nesterenko; Irina Yu Zarayskaya
Journal:  Biology (Basel)       Date:  2021-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.